Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults

European Neuropsychopharmacology

Volumn 10, Issue 5, 2000, Pages 305-314

  Philipp, M ^a   Tiller, J W G ^b   Baier, D ^c   Kohnen, R ^d  

^a Bezirkskrankenhaus Landshut   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROCHE INNOVATION CENTER MUNICH   (Germany)

^d IMEREM   (Germany)

Author keywords

Depression; Efficacy; Fluoxetine; Fluvoxamine; Moclobemide; Paroxeti ne; Rating scales; Sertraline; Sexual dysfunction; Tolerability

Indexed keywords

FLUOXETINE; FLUVOXAMINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ANORGASMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ERECTILE DYSFUNCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEXUAL DYSFUNCTION;

EID: 0033847625     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(00)00085-7     Document Type: Article

References (53)

1. Angst J. Sexual problems in healthy and depressed persons. Int. Clin. Psychopharmacol. 13:(Suppl. 6):1998;S1-S4.
2. Angst J., Johnson F.N. Moclobemide in special sub-groups of depression. Rev. Contemp. Pharmacother. 5:1994;45-55.
3. Araujo A.B., Durante R., Feldman H.A., Goldstein I., McKinlay J.B. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom. Med. 60:1998;458-465.
4. Baier D., Philipp M. Die Beeinflussung sexueller Funktionen durch Antidepressiva. Fortschritte Neurol. Psychiatrie. 62:1994;14-21.
5. Baier, D., Kohnen, R., Philipp, M., Tiller, J.W.G. Instruments for measuring treatment emergent sexual dysfunction in clinical trials: the patient sexual function questionnaire (Pat SFQ) and the physician sexual function rating (Phys SFR), in preparation.
6. Baldwin D.S. Psychotropic drugs and sexual dysfunction. Int. Rev. Psychiatry. 7:1995;261-273.
7. Balon R., Yerugani V.K., Pohl R., Ramesh C. Sexual dysfunction during antidepressant treatment. J. Clin. Psychol. 54:1993;209-212.
8. Casper R.C., Redmond D.E., Katz M.M., Schaffer C.B., Davis J.M., Koslow S.H. Somatic symptoms in primary affective disorder. Arch. Gen. Psychiatry. 42:1985;1098-1104.
9. Davidson J.R.T. Sexual dysfunction and antidepressants. Depression. 2:1995;233-240.
10. Fisher S., Kent T.A., Bryant S.G. Postmarketing surveillance by patient self monitoring: preliminary data for sertraline versus fluoxetine. J. Clin. Psychiatry. 56:1995;288-296.
11. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 12:1960;56-62.
12. Harrison W.M., Rabkin J.G., Ehrhardt A.A., Stewart J.W., McGrath P.J., Ross D., Quitkin F.M. Effects of antidepressant medication on sexual function: a controlled study. J. Clin. Psychopharmacol. 6:1986;144-149.
13. Harvey K.V., Balon R. Clinical implications of antidepressant drug effects on sexual function. Ann. Clin. Psychiatry. 7:1995;189-201.
14. Herman J.B., Brotman A.W., Pollak M.H., Falk W.E., Biederman J., Rosenbaum J.F. Fluoxetine-induced sexual dysfunction. J. Clin. Psychiatry. 51:1990;25-27.
15. Hirschfeld R.M.A. Sexual dysfunction in depression: disease- or drug-related. Depression Anxiety. 7:(Suppl. 1):1998;21-23.
16. Hsu J.H., Shen W.W. Male sexual side effects associated with antidepressant: a descriptive clinical study of 32 patients. Int. J. Psychiatry. 25:1995;191-201.
17. Jacobsen F.M. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J. Clin. Psychiatry. 53:1992;119-122.
18. Keller Ashton A., Hamer R., Rosen R.C. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J. Sex Marital Ther. 23:1997;165-175.
19. Kennedy S.H., Ralevski E., Davis C., Neitzert C. The effects of moclobemide on sexual desire and function in healthy volunteers. Eur. Neuropsychopharmacol. 6:1996;177-181.
20. Labbate L.A., Grimes J., Hines A., Oleshansky M.A., Arana G.W. Sexual dysfunction induced by serotonin reuptake antidepressants. J. Sex Marital Ther. 24:1998;3-12.
21. Labbate L.A., Grimes J.B., Arana G.W., Ralph H., Johnson V.A. Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disorders. Biol. Psychiatry. 15:1998;904-907.
22. Lane R.M. A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management. J. Psychopharmacol. 11:1997;72-82.
23. Linden M., Baier D., Beitinger H., Kohnen R., Osterheider M., Philipp M., Reimitz P.E., Schaaf B., Weber H.J. Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. Pharmacopsychiatry. 30:(Suppl):1997;65-70.
24. Litwin M.S., Nied R.J., Dhanani N. Health-related quality of life in men with erectile dysfunction. J. Gen. Intern. Med. 13:(3):1998;159-166.
25. Margolese H.C., Assalian P. Sexual side effects of antidepressants: a review. J. Sex Marital Ther. 22:1996;209-217.
26. McCabe M.P. Intimacy and quality of life among sexually dysfunctional men and women. J. Sex Marital Ther. 23:(4):1997;276-290.
27. Mitchell J.E., Popkin M.K. Antidepressant drug therapy and sexual dysfunction in men: a review. J. Clin. Psychopharmacol. 3:1983;76-79.
28. Modell J.G., Katholi C.R., Modell J.D., DePalma R.L. Comparative sexual side effects of bupropion, fluoxetine, paroxetine and sertraline. Clin. Pharmacol. Ther. 61:1997;476-487.
29. Montejo-Gonzalez A.L., Liorca G., Izquierdo J.A., Ledesma A., Bousono M., Calcedo A., Carrasco J.L., Giudad J., Daniel E., De La Gandara J., Derecho J., Franco M., Gomez M.J., Macias J.A., Martin T., Perez V., Sanchez J.M., Sanchez S., Vicens E. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicentre, and descriptive clinical study of 344 patients. J Sex Marital Ther. 23:1997;176-194.
30. Monteiro W.O., Noshirvani H.F., Marks I.M., Lelliott P.T. Anorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trial. Br. J. Psychiatry. 151:1987;107-112.
31. Murray J.B. Physiological mechanisms of sexual dysfunction side effects associated with antidepressant medication. J. Psychol. 132:1998;407-416.
32. Nelson J.C., Charney D.S. The symptoms of major depressive illness. Am. J. Psychiatry. 138:1981;1-12.
33. Olivier B., van Oorschot R., Waldinger M.D. Serotonin, serotoninergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int. Clin. Psychopharmacol. 13:(Suppl. 6):1998;S9-S14.
34. Patterson W.M. Fluoxetine-induced sexual dysfunction. J. Clin. Psychiatry. 54:(2):1993;71.
35. Philipp M., Kohnen R., Benkert O. A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int. Clin. Psychopharmacol. 7:1993;149-153.
36. Philipp M., Delini-Stula A., Baier D., Kohnen R., Scholz H.J., Laux G. Assessment of sexual dysfunction in depressed patients and reporting attitudes in routine daily practice: results of the postmarketing observational studies with moclobemide, a reversible MAO-A-inhibitor. Int. J. Psychiatry Clin. Pract. 3:1999;257-264.
37. Piazza L.A., Markowitz J.C., Kocsis J.H., Leon A.C., Portera L., Miller N.L., Adler D. Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study. Am. J. Psychiatry. 154:1997;1757-1759.
38. Priest R.G., Schmidt-Burgk W. Moclobemide in the treatment of depression. Rev. Contemp. Pharmacother. 5:1994;35-43.
39. Rand E.H. Priapism in a patient taking sertraline (letter). J. Clin. Psychiatry. 59:1998;538.
40. Reimherr F.W., Chouinard G., Cohn C.K., Cole J.O., Itil T.M., LaPierre Y.D., et al. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled multicenter comparison study in outpatients with major depression. J. Clin. Psychiatry. 51:(Suppl. B):1990;18-27.
41. Rosen R.C., Ashton A.K. Prosexual drugs: empirical status of the 'new aphrodisiacs'. Arch. Sex. Behav. 22:1993;521-543.
42. Rosen R.C., Lane R.M., Menza M. Effects of SSRIs on sexual function: a critical review. J. Clin. Psychopharmacol. 19:1999;67-85.
43. Segraves R.T. Antidepressant-induced sexual dysfunction. J. Clin. Psychiatry. 59:(Suppl. 4):1998;48-54.
44. Shen W.W., Hsu J.H. Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients. Int. J. Psychiatry. 25:1995;239-248.
45. Steffens D.C., Krishnan K.R., Helms M.J. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. Depress Anxiety. 6:1997;10-18.
46. Steiger A., Holsboer F., Benkert O. Long term studies on the effect of tricyclic antidepressants and selective MAO-A inhibitors on sleep, nocturnal penile tumescence and hormonal secretion in normal controls. Koella W.P. Sleep. 1988;335-337 GF Verlag, Stuttgart.
47. Thase M.E., Reynolds I.I.I.C.F., Jennings J.R., Frank E., Howell J.R., Houck P.R., Berman S., Kupfer D.J. Nocturnal penile tumenscence is diminished in depressed men. Biol. Psychiatry. 24:1988;33-46.
48. Tiller J.W.G., Johnson G.F., Burrows G.D. Moclobemide for depression: an Australian psychiatric practice study. J. Clin. Psychopharmacol. 15:(Suppl. 2):1995;31S-34S.
49. Tiller, J.W.G., Philipp, M., Baier, D., Kohnen, R., and the Australian and German Study Groups. Frequency of sexual dysfunction in depressed adults and impact on quality of life. J. Clin. Psychiatry, submitted.
50. Waldinger M.D., Berendsen H.H., Blok B.F., Olivier B., Holstege G. Premature ejaculation and serotonergic antidepressant-induced delayed ejaculation: the involvement of the serotonergic system. Behav. Brain Res. 92:1998;111-118.
51. Waldinger M.D., Hengeveld M.W., Zwinderman A.H., Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J. Clin. Psychopharmacol. 18:1998;274-281.
52. Waldinger M.D., Olivier B. Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int. Clin. Psychopharmacol. 13:(Suppl. 6):1998;S27-S33.
53. Zajecka J., Mitchell S., Fawcett J. Treatment-emergent changes in sexual function with selective serotonin inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol. Bull. 33:1997;755-760.